Cara Therapeutics Inc CARA Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Cara Therapeutics Inc (CARA)
Cara Therapeutics Inc (CARA) Financials

Cara Therapeutics Inc (CARA)

0.4636

0.0062

(1.36%)

Closed December 24 3:00PM

Delayed by 15 minutes

0.4271

-0.0365

( -7.87% )

Pre Market: 6:10AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-65.566	-72.28	-51.429	-50.202	3.337	-34.133	-39.821	-76.936
Return on Equity (%)	-73.545	-84.542	-67.159	-66.412	3.86	-37.119	-44.253	-109.803
Return on Invested Capital (%)	-74.334	-85.14	-77.165	-94.363	4.035	-53.122	-57.44	-119.691
Operating Margin (%)	-67148.837	-6402.744	-552.394	-539.017	5.714	-384.059	-204.156	-562.328
Net Profit Margin (%)	-66604.651	-6380.351	-549.506	-534.914	6.226	-384.059	-204.156	-565.209
Book Value Per Share	1.858	2.657	3.379	3.996	4.993	4.254	2.951	1.048
Earnings Per Share	-2.098	-1.78	-1.871	-2.277	0.169	-1.654	-1.589	-2.175
Cash Per Share	0.443	0.287	0.381	0.392	0.635	0.252	1.185	0.95
Working Capital Per Share	1.828	2.65	3.229	2.628	3.541	2.911	2.704	1.662
Operating Profit Per Share	0.003	0.028	0.341	0.426	2.709	0.431	0.648	0.272
EBIT Per Share	-2.116	-1.786	-1.881	-2.294	0.155	-1.654	-1.589	-2.175
EBITDA Per Share	-2.116	-1.786	-1.881	-2.294	0.155	-1.654	-1.589	-2.175
Free Cash Flow Per Share	-2.126	-1.793	-1.879	-2.281	0.171	-1.658	-1.593	-2.136

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	27.3M	32.66M	39.55M	46.72M	49.87M	53.48M	53.8M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	53.73M	53.8M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-432.522	N/A	N/A	N/A	-1344.918	N/A
Net Profit Margin (%)	N/A	N/A	-432.522	N/A	N/A	N/A	-1437.752	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	25.43M
Price to Earnings Ratio	-0.21
Price to Sales Ratio	1.2
Price to Cash Ratio	0.49
Price to Book Ratio	0.44
Dividend Yield	-

Share Statistics

Shares Outstanding	54.86M
Average Volume (1 week)	8.8M
Average Volume (1 Month)	3.6M
52 Week Change	-34.66%
52 Week High	1.15
52 Week Low	0.2257

More Ratios Coming Soon!

Cara Therapeutics

Tmt Acquisition

Gt.hall No1 Abs

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions